The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device - A MADIT-CRT substudy

Journal of Cardiac Failure

Volumn 20, Issue 3, 2014, Pages 183-189

  Aktas, Mehmet K ^a   Zareba, Wojciech ^a   Huang, David T ^a   McNitt, Scott ^a   Polonsky, Slava ^a   Chen, Leway ^a   Stockburger, Martin ^b   Merkely, Bela ^c   Moss, Arthur J ^a   Kutyifa, Valentina ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

cardiac resynchronization therapy; left bundle branch block; Weight loss

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; WEIGHT CHANGE; WEIGHT REDUCTION; CLINICAL TRIAL; CONTROLLED STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84896100090     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.12.012     Document Type: Article

References (21)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
2. C.J. Lavie, M.A. Alpert, R. Arena, M.R. Mehra, R.V. Milani, and H.O. Ventura Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure JACC 1 2013 93 102
3. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol 53 2009 1925 1932
4. A. Oreopoulos, R. Padwal, K. Kalantar-Zadeh, G.C. Fonarow, C.M. Norris, and F.A. McAlister Body mass index and mortality in heart failure: a meta-analysis Am Heart J 156 2008 13 22
5. A.J. Moss, W.J. Hall, and D.S. Cannom et al. Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
6. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
7. A.S. Tang, G.A. Wells, and M. Talajic et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
8. M.R. Bristow, L.A. Saxon, and J. Boehmer et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
9. A. Auricchio, M. Kloss, S.I. Trautmann, S. Rodner, and H. Klein Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay Am J Cardiol 89 2002 198 203
10. T. De Marco, E. Wolfel, and A.M. Feldman et al. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study J Card Fail 14 2008 9 18
11. W. Zareba, H. Klein, and I. Cygankiewicz et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Circulation 123 2011 1061 1072
12. C.M. Tracy, A.E. Epstein, and D. Darbar et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 1297 1313
13. A.J. Moss, M.W. Brown, and D.S. Cannom et al. Multicenter automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol Ann Noninvasive Electrocardiol 10 2005 34 43
14. S. Fulster, M. Tacke, and A. Sandek et al. Muscle wasting in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) Eur Heart J 34 2013 512 519
15. S.J. Pocock, J.J. McMurray, and J. Dobson et al. Weight loss and mortality risk in patients with chronic heart failure in the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programme Eur Heart J 29 2008 2641 2650
16. S.D. Anker, A. Negassa, and A.J. Coats et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
17. J.P. Curtis, J.G. Selter, and Y. Wang et al. The obesity paradox: body mass index and outcomes in patients with heart failure Arch Intern Med 165 2005 55 61
18. B. Choy, E. Hansen, A.J. Moss, S. McNitt, W. Zareba, and I. Goldenberg Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction Am J Cardiol 105 2010 581 586
19. C. Berry, and A.L. Clark Catabolism in chronic heart failure Eur Heart J 21 2000 521 532
20. S.D. Anker, P. Ponikowski, and S. Varney et al. Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
21. S. von Haehling, M. Lainscak, and W. Doehner et al. Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) J Cachexia Sarcopenia Muscle 1 2010 187 194